Top Purchase Related
Home
>
Node
>
Subnode

Insights on amprenavir, ABT-378/r, and nelfinavir

Aids Reader 10(3): 173

2000

ISSN/ISBN: 1053-0894
PMID: 10758020
Document Number: 525591

Document emailed within 1 workday
Secure & encrypted payments

Kuschak, D.; Mauss, S.; Schmutz, G.; Gantke, B. 2001: Simultaneous Determination of the New HIV Protease Inhibitor Lopinavir (ABT 378) and of Indinavir (1), Amprenavir, Saquinavir, Ritonavir (ABT 538) (2) and Nelfinavir (3) in Human Plasma by Gradient HPLC Clinical Laboratory 47(9-10): 471-477
Goodgame, J.C.; Pottage, J.C.; Jablonowski, H.; Hardy, W.D.; Stein, A.; Fischl, M.; Morrow, P.; Feinberg, J.; Brothers, C.H.; Vafidis, I.; Nacci, P.; Yeo, J.; Pedneault, L. 2000: Amprenavir in combination with lamivudine and zidovudine versus lamivudine and zidovudine alone in HIV-1-infected antiretroviral-naive adults. Amprenavir PROAB3001 International Study Team Antiviral Therapy 5(3): 215-225
Mathias, C.V.; Mathias, C.F.V.; Simões, M.J.; Amed, A.M.; Simões, R.S.; Oliveira-Filho, R.M.; Kulay, L. 2005: Safety of nelfinavir use during pregnancy. An experimental approach in rats Clinical and Experimental Obstetrics and Gynecology 32(3): 163-165
Lalezari, J.P.; DeJesus, E.; Northfelt, D.W.; Richmond, G.; Wolfe, P.; Haubrich, R.; Henry, D.; Powderly, W.; Becker, S.; Thompson, M.; Valentine, F.; Wright, D.; Carlson, M.; Riddler, S.; Haas, F.F.; DeMasi, R.; Sista, P.R.; Salgo, M.; Delehanty, J. 2003: A controlled Phase Ii trial assessing three doses of enfuvirtide (T-20) in combination with abacavir, amprenavir, ritonavir and efavirenz in non-nucleoside reverse transcriptase inhibitor-naive HIV-infected adults Antiviral Therapy 8(4): 279-287
Ford, J.; Cornforth, D.; Hoggard, P.G.; Cuthbertson, Z.; Meaden, E.R.; Williams, I.; Johnson, M.; Daniels, E.; Hsyu, P.; Back, D.J.; Khoo, S.H. 2004: Intracellular and plasma pharmacokinetics of nelfinavir and M8 in HIV-infected patients: relationship with P-glycoprotein expression Antiviral Therapy 9(1): 77-84
Kaeser, B.; Charoin, J.E.; Gerber, M.; Oxley, P.; Birnboeck, H.; Saiedabadi, N.; Banken, L. 2005: Assessment of the bioequivalence of two nelfinavir tablet formulations under fed and fasted conditions in healthy subjects International Journal of Clinical Pharmacology and Therapeutics 43(3): 154-162
Hoffmann, F.; Funk, M.; Linde, R.; Notheis, G.; Petropoulou, T.; Eberle, J.; Gürtler, L.; Belohradsky, B.H.; Wintergerst, U. 2002: Effect of antiretroviral triple combinations including the protease inhibitor nelfinavir in heavily pretreated children with HIV-1 infection European Journal of Medical Research 7(7): 330-334
Ben-Romano, R.; Rudich, A.; Etzion, S.; Potashnik, R.; Kagan, E.; Greenbaum, U.; Bashan, N. 2006: Nelfinavir induces adipocyte insulin resistance through the induction of oxidative stress: differential protective effect of antioxidant agents Antiviral Therapy 11(8): 1051-1060
Funk, M.B.; Linde, R.; Wintergerst, U.; Notheis, G.; Hoffmann, F.; Schuster, T.; Kornhuber, B.; Ahrens, P.; Kreuz, W. 1999: Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children Aids 13(13): 1653-1658
Sherman, K.E.; Shire, N.J.; Cernohous, P.; Rouster, S.D.; Omachi, J.H.; Brun, S.; Da Silva, B. 2005: Liver injury and changes in hepatitis C virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients : Lopinavir-ritonavir versus nelfinavir Clinical Infectious Diseases 41(8): 1186-1195
Lillibridge, J.H.; Liang, B.H.; Kerr, B.M.; Webber, S.; Quart, B.; Shetty, B.V.; Lee, C.A. 1998: Characterization of the selectivity and mechanism of human cytochrome P450 inhibition by the human immunodeficiency virus-protease inhibitor nelfinavir mesylate Drug Metabolism and Disposition: the Biological Fate of Chemicals 26(7): 609-616
Reiser, M.; Salzberger, B.; Stiepel, A.; Hoetelmans, R.; Diehl, V.; Fätkenheuer, G. 1999: Virological efficacy and plasma drug concentrations of nelfinavir plus saquinavir as salvage therapy in HIV-infected patients refractory to standard triple therapy European Journal of Medical Research 4(2): 54-58
Gartland, M. 2001: AVANTi 3: a randomized, double-blind trial to compare the efficacy and safety of lamivudine plus zidovudine versus lamivudine plus zidovudine plus nelfinavir in HIV-1-infected antiretroviral-naive patients Antiviral Therapy 6(2): 127-134
Moolasart, P.; Likanonsakul, S. 2002: The efficacy of combined zidovudine and lamivudine compared with that of combined zidovudine, lamivudine and nelfinavir in asymptomatic and early symptomatic HIV-infected children Southeast Asian Journal of Tropical Medicine and Public Health 33(2): 280-287
Corty, F.L. 1977: Land use issues and insights DAE Research Report, Louisiana Agricultural Experiment Station 519: 40
Hostetter, M.K. 1996: New insights into candidal infections Advances in Pediatrics 43: 209-230
Maendel, C.M.; Blumhardt 2001: New insights into mental illness American Family Physician 63(1): 41
Putre, L. 2013: Fresh insights at the table Trustee: the Journal for Hospital Governing Boards 66(8): 29-31; 1
Kujala, G.A. 1986: Lyme disease: new insights Delaware Medical Journal 58(9): 583-586; 591-593
Pallarito, K. 1993: GAO lauds Rochester 'insights' Modern Healthcare 23(12): 17